There is an exciting opportunity to advance the field of neurodegenerative diseases by developing animal models that accurately recapitulate key features of human pathology. In parallel, the ...

The global mice model market is set to witness a growth rate of ~9% in the next 5 years. Increasing demand for personalized ...

Parkinson's disease causes both movement and cognitive deficits, and for a long time both were thought to be caused by the ...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced the launch of a humanized transgenic ...

Cutting-edge machine learning tools reveal hidden patterns in Alzheimer’s disease mouse behavior, opening the door to innovative treatments targeting neuroinflammation. Study: Machine learning reveals ...

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain cells and fuels Parkinson’s disease. In mouse models, restoring the ...

The lack of animal models that mimic human disease impedes the study of many pathologies that still lack treatment beyond symptom relief. This is what has happened so far with PURA syndrome, a rare ...

Research shows that Semaglutide not only improves memory and learning in Alzheimer's models, but also reduces harmful plaques and proteins, while restoring the neuroprotective effects of oxytocin.